期刊文献+

肺耐药蛋白在乳腺癌中的表达及临床意义 被引量:3

Expression and Clinical Significance of Lung Resistance Protein in Breast Cancer
下载PDF
导出
摘要 目的研究乳腺癌组织中肺耐药蛋白(lung resistance protein,LRP)的表达,探讨其在乳腺癌多药耐药机制中的作用及其临床意义。方法2000年首都医科大学附属北京友谊医院普通外科收治的乳腺癌病例81例,均为女性,年龄30至83岁(平均年龄53.2岁),接受以手术为主的综合治疗且均未进行新辅助化疗。病理类型包括浸润性导管癌、浸润性小叶癌、单纯癌、黏液癌和早期浸润癌。根据2003版国际抗癌联盟(International Union Against Cancer,UICC)乳腺癌分期标准进行临床病理分期,Ⅰ期:17例,Ⅱ期:43例,Ⅲ期:21例。术后5年随访者36例,无瘤生存30例,转移6例(带瘤生存1例,死亡5例)。制作组织芯片,采用SP免疫组化染色法,测定81例未经过新辅助化疗的乳腺癌标本中LRP的表达,与临床病理因素及雌激素受体(estrogen receptor,ER)、孕激素受体(progesterone receptor,PR)、抑癌基因p53(p53)、人表皮生长因子受体2(Her-2)、增生细胞核抗原Ki-67(Ki-67)的表达进行相关性分析。应用χ2检验及等级相关检验,使用SPSS11.5统计学软件进行数据处理及分析。结果乳腺癌组织中LRP的阳性表达率为70.4%(57/81)。老年患者的LRP表达比中青年患者明显降低(P<0.05);LRP的表达与病理分期、预后无相关关系(P>0.05)。LRP与ER和PR的表达存在一定的正相关关系,相关系数分别为0.327、0.264(P<0.05);LRP与p53、Her-2、和Ki-67的表达无相关关系(P>0.05)。结论LRP在乳腺癌组织中有较高的表达率,与年龄及ER、PR的表达有关,本结果为临床化疗药物的选择提供了依据。 Objective To investigate the expression of lung resistance protein(LRP) genes in breast cancer and to explore the role of multi-drug resistance mechanism in breast cancer and its clinical significance.Methods Totally 81 female cases of breast cancer,who were treated in the department of general surgery of Beijing Friendship Hospital in 2000,aged 30~83 years(average 53.2 years),accepted the comprehensive treatment with surgery without neoadjuvant chemotherapy.Pathological types included invasive ductal carcinoma,invasive lobular carcinoma,the only cancer,mucus cancer and early invasive cancer.According to standards of International Union Against Cancer(UICC) 2003 version for clinicopathological staging of breast cancer,17 cases were at stage Ⅰ,43 cases stage Ⅱ,and 21 cases stage Ⅲ.Thirty-six cases had five-year follow-up results,30 cases had disease-free survival for 5 years,6 cases had metastasis(1 case survived with tumor and 5 cases died).Tissue chips were prepared.LRP expression in breast cancer tissue was determined by using immunohistochemistry and in situ hybridization,and other detection technology.Results According to manual reagents criteria of Maixin company,the results were separated into negative(-/+) and positive(++/+++).The positive rate of LRP in breast cancer was 70.4%(57/81).The 81 cases were divided into two groups:young and middle-aged group(age〈50 years,36 cases) and elderly group(≥50 years,45 cases).It was found that positive correlation was not only found between LRP and ER but also between LRP and PR.The correlation coefficient were 0.327,0.264,P〈0.05.But there was no correlation between LRP and p53,Her-2 and Ki-67,P〉 0.05.Conclusion The expression of LRP increased in breast cancer evidently,there was correlation between the LRP expression and age,expression of ER and PR,which may provide basis for selecting the drug of chemotherapy.
出处 《首都医科大学学报》 CAS 北大核心 2009年第5期699-702,共4页 Journal of Capital Medical University
关键词 乳腺癌 多药耐药 肺耐药蛋白 breast cancer multidrug resistance lung resistance protein
  • 相关文献

参考文献8

  • 1Scheper R J,Broxterman H J,Scheffer G L,et al.Overexpression of a Mr 110,000 resicular protein in non-P-glocoprotein mediated multidrug resistance[J].Cancer Res,1993,53:1475-1479.
  • 2Schneider J,Gonzalez-Roces S,Pollan M,et al.Expression of LRP and MDR1 in locally advanced breast cancer predicts axillary node invasion at the time of rescue mastectomy after induction chemotherapy[J].Breast Cancer Res,2001,3:183-191.
  • 3Meschini S,Marra M,Calcabrini A,et al.Role of the lung resistance correlated protein(LRP) in the drug sensitivity of cultured tumor cells[J].Toxicol In Vitro,2002,16:389-398.
  • 4穆殿斌,仲伟霞,贺爱丽,刘自芬.乳腺癌P-gp、LRP、GST-π、TOPO-Ⅱ的表达及其与术前化疗的关系[J].实用医技杂志,2004,11(08B):1530-1532. 被引量:1
  • 5Pohl G,Filipits M,Suchomel R W,et al.Expression of lung resistance protein(LRP) in primary breast cancer[J].Anticancer Res,1999,19:5051-5059.
  • 6谭敏,宾晓农,何青莲,刘鹏熙,胥健敏,赵虹,杨海峰.乳腺癌组织中耐药相关基因表达的研究[J].广州中医药大学学报,2005,22(3):200-202. 被引量:7
  • 7Filipits M,Pohl G,Stranzl T,et al.Expression of the lung resistance protein predicts poor outcome in de novo acute myeloid leukemia[J].Blood,1998,91:1508-1513.
  • 8Oide H,Minegishi A,Kobayashi S,et al.Evaluation of p21 and lung resistance protein(LRP) as a factor suggesting breast cancer recurrence[J].Nippon Geka Gekkai Zasshi,2000,101:242-248.

二级参考文献11

共引文献6

同被引文献35

  • 1侯志斌,陈亮.乳腺癌患者MMP9和C-erbB-2的表达及意义[J].青海医药杂志,2008,38(4):4-6. 被引量:2
  • 2徐晓妹,林惠忠,鲁杰,张日民,黄维青,林兆武.多药耐药基因MDR1及P-gp蛋白在乳腺癌组织中的表达及临床意义[J].肿瘤防治杂志,2005,12(15):1150-1153. 被引量:10
  • 3Parkin DM,Bray F,Ferlay J. Global cancer statistics 2002[J].CA:A Cancer Journal for Clinicians,2005,(02):74-108.doi:10.3322/canjclin.55.2.74.
  • 4Yang JM,Xu ZD,Wu H. Overexpression of extracellular matrix metalloproteinase inducer in multidrug resistant cancer cells[J].Molecular Cancer Research,2003,(06):420-427.
  • 5Reimers N,Zafrakas K,Assmann V. Expression of extracellular matrix metalloproteases inducer on micrometastatic and primary mammary carcinoma cells[J].Clinical Cancer Research,2004,(10):3422-3428.
  • 6Toole BP,Marieb EA,Zoltan-Jones A. Emmprin promotes anchorage-independent growth in human mammary carcinoma cells by stimulating hyaluronan production[J].Cancer Research,2004,(04):1229-1232.doi:10.1158/0008-5472.CAN-03-2832.
  • 7Miletti-Gonzalez KE,Chen S,Muthukumaran N. The CD44 receptor interacts with P-glycoprotein to promote cell migration and invasion in cancer[J].Cancer Research,2005,(15):6660-6667.
  • 8Molinari A,Colone M,Calcabrini A. The multidrug transporter P-glycoprotein:A mediator of melanoma invasion[J].J Investigative Dermatol,2008,(04):957-971.
  • 9Zhang N,Zhang F,Zhang L. Anxa2 plays a critical role in enhanced invasiveness of the multidrug resistant human breast cancer cells[J].Journal of Proteome Research,2009,(11):5041-5047.doi:10.1021/pr900461c.
  • 10Muimo R. Regulation of CFTR function by annexin A2-S100A10 complex in health and disease[J].General Physiol Biophysics,2009.14-19.

引证文献3

二级引证文献50

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部